Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v3.20.1
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended
Mar. 28, 2020
Mar. 30, 2019
Income Statement [Abstract]    
Net sales $ 295,836,000 $ 287,659,000
Cost of sales (exclusive of depreciation and amortization shown separately below) 166,411,000 165,921,000
Selling, general and administrative expenses 89,753,000 91,835,000
Depreciation 17,517,000 15,816,000
Amortization 14,848,000 14,765,000
Management fees to related party 125,000 131,000
Other income (2,264,000) (1,074,000)
Income from operations 9,446,000 265,000
Interest expense, net 23,180,000 26,563,000
Interest expense on junior subordinated debentures 3,152,000 3,152,000
Gain (Loss) on Interest Rate Derivative Instruments Not Designated as Hedging Instruments 2,250,000 1,113,000
Investment income on trust common securities (95,000) (95,000)
Loss before income taxes (19,041,000) (30,468,000)
Income tax (benefit) expense (9,290,000) 4,800,000
Net loss (9,751,000) (35,268,000)
Net loss from above (9,751,000) (35,268,000)
Other comprehensive loss:    
Foreign currency translation adjustments (11,213,000) 2,779,000
Total other comprehensive income (loss) (11,213,000) 2,779,000
Comprehensive loss $ (20,964,000) $ (32,489,000)